Stent recalls could hit inventory The three recalls of Boston Scientific Corp. cardiac stents since July 2 affected many more units than the company has previously disclosed, raising concerns among stock analysts about future inventory levels. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 